Menu
Back to User profile » Dr Dionisiοs Spyratos
Papers published by Dr Dionisiοs Spyratos:
An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece
Mountzios G, Lampaki S, Koliou GA, Vozikis A, Kontogiorgos I, Papantoniou P, Koufaki MI, Res E, Boutis A, Christopoulou A, Pastelli N, Grivas A, Aravantinos G, Lalla E, Oikonomopoulos G, Koumarianou A, Spyratos D, Bafaloukos Snr D, Rigakos G, Papakotoulas P, Fountzilas G, Linardou H
Lung Cancer: Targets and Therapy 2021, 12:93-102
Published Date: 30 August 2021
Chronic obstructive pulmonary disease in patients with lung cancer: prevalence, impact and management challenges
Spyratos D, Papadaki E, Lampaki S, Kontakiotis T
Lung Cancer: Targets and Therapy 2017, 8:101-107
Published Date: 7 August 2017
Umeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: a review
Spyratos D, Sichletidis L
Therapeutics and Clinical Risk Management 2015, 11:481-487
Published Date: 25 March 2015
Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach
Petridis D, Zarogoulidis P, Kallianos A, Kioumis I, Trakada G, Spyratos D, Papaiwannou A, Porpodis K, Huang H, Rapti A, Hohenforst-Schmidt W, Zarogoulidis K
Therapeutics and Clinical Risk Management 2014, 10:77-86
Published Date: 7 February 2014
The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
Zarogoulidis K, Boutsikou E, Zarogoulidis P, Darwiche K, Freitag L, Porpodis K, Latsios D, Kontakiotis T, Huang H, Li Q, Hohenforst-Schmidt W, Kipourou M, Turner JF, Spyratos D
OncoTargets and Therapy 2013, 6:1493-1500
Published Date: 22 October 2013
Vitamin D in asthma and future perspectives
Huang H, Porpodis K, Zarogoulidis P, Domvri K, Giouleka P, Papaiwannou A, Primikyri S, Mylonaki E, Spyratos D, Hohenforst-Schmidt W, Kioumis I, Zarogoulidis K
Drug Design, Development and Therapy 2013, 7:1003-1013
Published Date: 23 September 2013
Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies
Hohenforst-Schmidt W, Zarogoulidis P, Darwiche K, Vogl T, Goldberg EP, Huang H, Simoff M, Li Q, Browning R, Turner FJ, Le Pivert P, Spyratos D, Zarogoulidis K, Celikoglu SI, Celikoglu F, Brachmann J
Drug Design, Development and Therapy 2013, 7:571-583
Published Date: 18 July 2013
Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today
Kallianos A, Tsimpoukis S, Zarogoulidis P, Darwiche K, Charpidou A, Tsioulis I, Trakada G, Porpodis K, Spyratos D, Panoutspoulos A, Veletza L, Kostopoulos K, Kostopoulos C, Karapantzos I, Tsakiridis K, Hohenforst-Schmidt W, Zarogoulidis K, Rapti A, Syrigos K
OncoTargets and Therapy 2013, 6:609-613
Published Date: 31 May 2013